Massive tissue eosinophilia is an outstanding feature of allergic disorders. By releasing various highly toxic mediators, eosinophils constitute the most important effector cells in inflammation associated with allergic diseases. Local accumulation of eosinophils consists of a multi-step process, but growing evidence has clearly indicated that the CC chemokine eotaxin plays a major role in the recruitment and activation of eosinophils at inflamed tissue sites. Results from our and other laboratories have revealed that production of eotaxin is precisely regulated by a Th1/Th2 balance in favor of Th2: eotaxin generation is up-regulated by IL-4 1 and downregulated by IFN-␥. 2 The eotaxin gene is located in the C-C chemokine cluster, ie, chromosome 17q11.2, 3 and the promoter contains overlapping consensus binding sites for transcription factors NF-B and STAT6 at −128 to −113 4 . Although it is highly conceivable that structural variations as well as dysregulation of eotaxin expression is associated with susceptibility to allergic diseases such as asthma, no systematic screening for polymorphisms of the eotaxin gene (SCYA11: GenBank, AC 005549 and Z92709) has been reported to date. In the present study, we for the first time have performed polymorphism screening of the coding and promoter regions of the eotaxin gene.
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Systematic screening of the entire coding regions, 5Ј and 3Ј untranslated regions, and the promoter region (ෂ −447 bases) of eotaxin for gene variations was performed on genomic DNA samples from 38 healthy and 16 asthmatic Japanese individuals, using a polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) method. 5 The human eotaxin gene consists of three exons, and each exon was amplified using flanking intronic primer sets, except for exon 3, which was divided into two fragments due to the length of the exon (Table 1) . Thus, among the introns, only 30-80 nucleotides flanking each exon were screened. The nucleotide sequences of the detected variations were determined by direct sequencing. Using this approach, two novel nucleotide sequence variations were identified in the coding region of the eotaxin gene. AC to T single nucleotide synonymous substitution (S4S) was detected at position 12 (counting from the ATG start codon) (c.12CϾT; the designations of the variations are based on Dunnen and Antonarakis 6 ). This variant was detected in only one healthy individual. A G to A single nucleotide substitution was detected at position 67, which resulted in a non-conservative amino acid change of Ala at position 23 to Thr (A23T) within the signal peptide. The 5Ј-flanking regions of the eotaxin gene were separated in three fragments of appropriate size, ie, −467/−242 (225 bp), −275/−64 (211 bp) and −121/+124 (245 bp), for the genotyping. Genotyping of the upstream fragment was successfully performed using PCR-SSCP followed by direct sequencing. Two single nucleotide substitutions were The −426CϾT polymorphism was genotyped by PCR-RFLP analysis using TthHB8I restriction enzyme and EX-A1/B1 primers. The −384CϾT polymorphism was genotyped by PCR-RFLP analysis using TthHB8I restriction enzyme and EX-MS2/B1 primers.
detected: C to T at position −426 (−426CϾT), and A to G at position −384 (−384AϾG).
In the next series of experiments, the genotypes at the three common polymorphic sites were determined in 79 healthy Japanese individuals and 55 Japanese patients with asthma. The patients and controls were unrelated Japanese living in the Tokyo area. The patients were diagnosed according to the generally accepted criteria. c.67GϾA was genotyped using PCR-SSCP, and −426CϾT was genotyped by a PCR-restriction fragment length polymorphism (PCR-RFLP) method 8 using TthHB8I. For −384AϾG, a TthHB8I-restriction endonuclease polymorphism site was created using PCR with a mismatched primer (Table 1) , and the genotype was determined by RFLP. The genotype and allele frequencies of three single nucleotide polymorphisms (SNPs) are listed in Table 2 . No significant association was observed between these SNPs and susceptibility to asthma. We next estimated the statistical significance for a larger sample size. If the sample size for both the patients and healthy individuals was increased 8.1-fold (−426CϾT), 15.5-fold (−384AϾG) or 3.7 fold (c.67GϾA), P values of all variations reached 0.05. When the allelic associations among these three SNP sites were analyzed in the 79 healthy Japanese subjects, significant linkage disequilibrium was observed between positions −426 and −384, and also between −384 and +67 (Table 3) .
Increasing evidence has revealed the existence of disease-associated loci and genes in allergic disorders over the past 10 years. MHC ClassII, Fc⑀RI-␤, IgE, TCR␣, mast cell chymase, TAP1 and ␤-adrenergic receptor are implicated as candidates for the susceptibility genes to allergic diseases. Furthermore, genetic contributions of polymorphism of cytokines and their receptors, such as of IL-10, IL-4, IL-4R, IL-13, TGF␤ and TNF␣, to allergic disorders have also been reported. [9] [10] [11] The same situation is also observed with chemokines. Genome-wide linkage analysis demonstrated linkage of asthma to chromosome 17p12-17q11.2 (C-C chemokine cluster) in African-American sib pairs, and a recent report revealed that a functional mutation in the promoter region of a CC chemokine RANTES is associated with atopic dermatitis but not with asthma. 12 In the present study, we for the first time screened for polymorphisms of the eotaxin gene and found three SNPs and one rare variant in its coding and promoter regions. Such novel information will become important in genomic approaches to allergic disorders. The only amino acid change observed in this study, A23T, was not predicted to affect the cleavage of the signal peptide, 13 and the two SNPs in the promoter region do not alter the binding motifs for the transcriptional factors known to be important in regulation of the eotaxin gene. However, functional studies are necessary to examine whether these SNPs may be associated with a difference in the function or expression level. Because of the relatively small number of the patients, the association study described in this paper should be considered to be preliminary. In this context, large-scale case-controlled studies with age-and sex-matched controls and family-based association studies in patients with asthma and other allergic diseases such as atopic dermatitis will be of particular interest in the future. In addition, since it is likely that a complex interaction between multiple genetic factors is involved in the development of asthma, further studies should also focus on the relationship of these variants to those in other candidate genes for asthma.
Note
After submission of the paper, sequencing variations of chromosome 17q11.2 were reported (NT-010780, Homo sapiens chromosome 17 working draft sequence segment, HF, haplotype frequency; LD, linkage disequilibrium parameter; RLD, relative linkage disequilibrium value. The haplotype frequencies were estimated using the EH program. 14 Relative linkage disequilibrium values were estimated from the genotypes of the healthy Japanese individuals using the difference between observed and expected frequencies of allele combination, standardized for the maximum possible value. 15 
